pCAG-MCS2-FOS (kindly provided by Dr. Morita), pLVX-TetOne (Takara), pCSII-EF-RfA, and pCSII-CMV-MCS-IRES2-Bsd (kindly provided by Dr. Miyoshi) vectors via sub-cloning. Site-directed mutagenesis was performed by overlap extension PCR using PrimeSTAR GXL DNA polymerase (Takara).
Hematologic analysis
Mice were anesthetized and immediately bled retro-orbitally into an EDTA-coated tube. Total cell counts were determined using a hemocytometer, and differential cell counts were performed using an automated hematology analyzer (Hemavet 850; Drew Scientific, Oxford, CT, or Sysmex, XT2000i). For BM cells, total cell counts were determined using a hemocytometer, and differential cell counts were conducted by microscopic analysis of Wright-Giemsa-stained cytospins or FACS analysis using a CANTOII flow cytometer with FACSDiva software (BD Biosciences, Franklin Lakes, NJ). The absolute number of neutrophils was then determined based on the cytospin or FACS analysis.
Human primary neutrophil isolation
Human primary neutrophils were isolated from apheresis-derived buffy coats provided by the Blood Bank Lab at the Boston Children's Hospital as previously described (Loison et al., 2014) . All blood is drawn from healthy blood donors. All protocols have been approved by the Children's Hospital Institutional Review Board (IRB).
Preparation of highly purified neutrophils (HPNs)
To examine GSDMD and ELANE expression in neutrophils, we used highly purified neutrophils (HPNs). Traditional neutrophil isolation using Ficoll or Percoll gradients only reach ~95% purity, and contamination with other cell types (e.g., monocytes) is inevitable. Therefore, we purified neutrophils from human blood using the traditional Ficoll method followed by negative selection to obtain HPNs (~99.5%). Briefly, human neutrophils were first prepared from apheresis-derived buffy coats using Ficoll as described above. The isolated neutrophils were further purified using the EasySep human neutrophil enrichment kit (StemCell Technologies, Cambridge, UK) according to the manufacturer's protocol. Neutrophil purity was determined by Wright-Giemsa staining.
Murine bone marrow neutrophil isolation
Murine bone marrow neutrophils were isolated from the femur and tibia as previously described . Briefly, bone marrow cells were collected from 8-14 weeks old mice and layered over discontinuous Percoll/HBSS gradients (52%, 64%, 76%) and centrifuged (1060g, 30 min, RT). The interface between the 64% and 76% layers containing neutrophils was harvested. Each preparation yielded about 7-11 million mature neutrophils (>85% purity).
Murine peripheral blood neutrophil isolation
8-14 weeks old mice were sacrificed by euthanizing with CO2 and immediately bleed by cardiac puncture. The peripheral blood (1-2 ml) was then diluted with 3 ml HBSS with 15 mM EDTA. Cells were spun down (500g, 10 min, RT) and washed once with 4 ml HBSS with 15 mM EDTA. Red blood cells were lysed by resuspension in 5 ml ACK (Ammonium-Chloride-Potassium) Lysing Buffer (Thermo Fisher Scientific) for 5 min at RT. Lysis was stopped by addition of 15 ml RPMI+2% FBS followed by centrifugation at 400g for 5 min. After being washed with isolation buffer (2 mM EDTA, 1% endotoxin-free BSA in HBSS), the cells were resuspended in 6 ml 45% Percoll/HBSS, layered over two other discontinuous Percoll/HBSS gradients (3 ml 81% and 4.5 ml 62%), and centrifuged at 1500g at room temperature for 30 minutes (no brake, no acceleration). The interface between the 62% and 81% layers containing neutrophils was harvested and washed once with 10 ml of isolation buffer (1200g, 5 min). The purified neutrophils were resuspended in RPMI 1640 medium containing 10% heatinactivated FBS and maintained at 37°C. Each preparation routinely yielded >1 million neutrophils (per mouse) with a purity of above 90% by Wright-Giemsa staining and FACS analysis with Gr-1 and CD11b monoclonal antibodies.
Neutrophil death analysis by FACS
Murine or human neutrophils were cultured in RPMI 1640 supplemented with 10 % heat-inactivated low endotoxin (≤ 5 EU/ml, usually ≤ 1 EU/ml) fetal calf serum (FCS, Gibco) and Penicillin-Streptomycin antibiotics at a density of 2 × 10 6 cells/ml at 37 o C in a 5% CO2 incubator. After indicated time periods, cells were then harvested, washed twice with ice cold PBS and stained with human Annexin V (FITC labeled, Invitrogen) and propidium iodide (PI) following a protocol provided by the manufacturer.
FACS was performed using a CANTOII flow cytometer (Becton Dickinson, San Jose, CA). At least ten thousand events were recorded and analyzed using FlowJo software (Tree Star). In this FACS analysis, cell debris were eliminated by appropriate gating on forward and side scatter. -/- or wild-type mice were intraperitoneally injected with 5x10 Peritoneal exudate cells were then harvested by 3 successive washes with 10 ml HBSS containing 0.2% BSA and 20 mM EDTA. The exudate cell count (total cell number) was determined using a hemacytometer and the differential cell count was determined by FACS analysis. The cells were incubated with FITC anti-Gr1 antibody or anti-rat IgG antibody (as a control) for 15 min at room temperature. After being washed twice with PBS containing 2% BSA, the cells were analyzed by a BD FACSCanto II flow cytometer (BD Biosciences). Total number of neutrophils in the peritoneal exudates was then calculated accordingly as previously described (Bajrami et al., 2016) . For measurement of cytokine levels in peritoneal cavity, peritoneal lavage fluids (PLF) were collected using 2 ml PBS/15 mM EDTA. Chemokine and cytokine levels in PLF were determined using ELISA kits.
Mouse peritonitis model

GSDMD
Bacterial burden
Mouse peritonitis was induced as described above. Peritoneal lavage fluid (PLF) was collected by 3 successive washes with 10 ml HBSS containing 0.2% BSA and 20 mM EDTA. PLFs were then serially diluted in ice-cold sterile PBS, and aliquots were spread on Luria broth (LB) agar plates. After overnight incubation at 37C, colonies were counted, and bacterial viability was expressed as colony-forming units (cfu) in total lavage fluid.
TG induced neutrophil recruitment to flamed peritoneal cavity
Peritonitis was induced by intraperitoneal injection of 3% thioglycollate (TG) solution as previously described . Peritoneal lavage fluids were collected from wild-type and GSDMD knockout mice by 3 successive washes with 10 ml HBSS containing 0.2% BSA and 20 mM EDTA, 7 hr after TG injection. The exudate cell count (total cell number) was determined using a hemacytometer and the differential cell count was determined by FACS analysis. The cells were incubated with FITC anti-Gr1 antibody for 15 min at room temperature. After being washed twice with PBS containing 2% BSA, the cells were analyzed by a BD FACSCanto II flow cytometer (BD Biosciences). Total number of neutrophils in the peritoneal exudates was then calculated accordingly.
In vitro bactericidal assay
Live E. coli particles (ATCC 19138 g/ml to kill extracellular bacteria. After an additional 15 min incubation, cells were washed twice with HBSS and lysed with 1 ml sterile water at room temperature. Samples were serially diluted and spread on LB agar plates. Colonies were counted after overnight incubation at 37°C.
In vitro Phagocytosis assay
Fluorescein-conjugated Phrodo TM Green E.coli bioparticles (Invitrogen) were reconstituted in HBSS and opsonized with 12.5% mouse serum at 37°C for 30 min. Mouse bone marrow neutrophils were incubated with serum-opsonized bioparticles at a ratio of 1:10 (neutrophils : bioparticles), and incubated at 37°C for 1 hour. Negative controls were incubated on ice for 1 hour. The assays were terminated by cooling the cells on ice. The number of internalized particles was counted under a fluorescence microscope (Olympus lX17, 100X objective). Phagocytosis index was expressed as the number of the internalized particles per 100 neutrophils. Phagocytosis efficiency was expressed as the percentage of neutrophils that engulfed at least one bioparticle. More than 200 cells were counted from random fields per coverslip for each group.
Recombinant protein expression
Human and mouse pET SUMO-GSDMD plasmids were transformed into BL21(DE3) competent cells for protein overexpression. E. coli organisms were pre-cultured in 2 ml LB medium containing 50µg/ml kanamycin at 37ºC overnight. 2 ml bacteria culture was then transferred into 300 ml LB medium containing 50 µg/ml kanamycin and further cultured at 37ºC to an OD 600 of 0.5-0.8. Subsequently, isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 1mM was added to the culture medium to induce protein expression. E. coli cultures were further incubated at 25ºC overnight. Cells were collected by centrifugation at 5000 rpm for 10 min and stored at -80°C. 6xHis-SUMO fusion GSDMD protein purification was carried out under native conditions using a Ni-NTA Fast Start kit (Qiagen, Limburg, NL). Following elution from the Ni-NTA affinity column with native elution buffer, the proteins were dialyzed in PBS overnight at 4ºC and stored at -80ºC.
Preparation of neutrophil lysate
Purified neutrophils were washed once with ice cold PBS then incubated for 30 min on ice in Triton lysis buffer (20 mM Tris-HCl (pH 7.4), 135 mM NaCl, 1% Triton X-100, 10% glycerol). Samples were centrifuged at 14,000 rpm for 30 min at 4°C. The supernatant was collected and stored at -80°C.
In-gel digestion and LC/MS/MS analysis
N-terminal His-tagged recombinant GSDMD (20 µg) was incubated with recombinant ELANE or neutrophil lysate (7 µg of protein) at 37 °C for 1 h. His-tagged proteins were then enriched by precipitation using Ni-NTA beads in the presence of DFP (100 µM). After three washes, His-tagged proteins were eluted using imidazole and resolved by SDS-PAGE. In-gel digestion was performed manually in 96-well plate format. Gel bands were first cut and diced into ~1mm cubes and transferred into the wells before being de-stained with 50/50 acetonitrile/50mM NH4HCO3 solution, dithiothritol (DTT)-reduced and iodoacetamide (IAM)-alkylated, followed by trypsin or AspN digestion overnight at 37°C. Peptides were extracted into 40/60 acetonitrile/0.1% formic acid solution and dried in a SpeedVac. The dry peptide extract was reconstituted in 22 µL 2%/0.2% acetonitrile/formic acid solution and analyzed on a 1D nanoLC-MS/MS platform using a standardized 110 min method (Mass Spec Facility, Broad Institute, MA). Peptides were separated on a C18-AQ column (75 μm × 50 cm, ReprosilPur C18-AQ, 1.9 μm) at 275 nl/min and analyzed on a QExactive Plus mass spectrometer in datadependent acquisition (DDA) mode with MS1 at 35000 and MS2 at 17500 resolution, respectively.
Database search
MS data were first QC checked using in-house developed software (Mass Spec Facility, Broad Institute) and subsequently searched against the modified Swiss-Prot human database using Andromeda integrated into MaxQuant with mass tolerance of 20 ppm (MS1) and 4.5 ppm (MS2). The modified Swiss-Prot human database includes all Gasdermin-D protein sequences derived by sequential C-terminal amino acid removal. Protein identification and concentration were directly reported from MaxQuant and then further processed using an in-house developed pipeline for protein identification and quantitation.
Western blotting
Neutrophils (4 million cells/data point) were centrifuged and lysed immediately with 100 µl boiling protein loading buffer containing protease inhibitor cocktail (Invitrogen, Carlsbad, CA) and DFP (2mM). Samples were incubated at 100ºC for 5 min and transferred to ice. After brief sonication (5-10 s), 25 µl of cell lysate was subjected to 5-20% gradient SDS-PAGE. Proteins were transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). After blocking the membranes in TBS containing 5% BSA (Sigma) and 0.02% Triton X-100 for 1 h, primary antibodies were added in blocking solution at the following dilutions: mouse anti-GSDMD antibody (Abnova, Taiwan, 1:1000), anti-Caspase-1 (Adipogen, San Diego, CA, 1:1000), anti-human and mouse ELA2 antibodies (R&D Systems, Minneapolis, MN, 1:1000), mouse anti-actin and FLAG antibodies (Sigma, 1:2000) . Primary antibody incubations were at 4°C overnight. After washing, goat HRP-conjugated secondary antibodies (Santa Cruz Biotechnology Inc., Dallas, TX) were added (1:10,000) in blocking solution and the membrane incubated at RT for 1 h. The immunocomplexes were detected with Super Signal West Femto substrate (Pierce, Rockford, IL) using an ImageQuant LAS-4000 (GE, Fairfield, CT).
Densitometry was performed using ImageJ software Gel Analyzer plug-in (Luo et al., 2002) .
Neutrophil elastase activity assay
The ELANE chromogenic substrate MeOSuc-Ala-Ala-Pro-Val-pNA was purchased from Santa Cruz Biotechnology Inc. Cleavage of p-nitroaniline (pNA) from the substrate by ELANE increases absorbance at 405 nm. For mouse ELANE activity, recombinant ELANE (0.1 µg) was incubated with the substrate (500 µM) in 100 ul of MES reaction buffer (50 mM MES pH 5.5, 50 mM NaCl) at 37ºC for 60 min. For human ELANE activity, the indicated amount of recombinant ELANE was incubated with the substrate (500 µM) in 100 ul of PBS at 37ºC for 30 min. Cleavage of the substrate product was detected at OD 405 in a 96-well microplate reader.
Lactate dehydrogenase (LDH) cytotoxicity assay
LDH release was assayed using the CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI) following the manufacturer's protocol. HEK293T cells were transfected with indicated GSDMD expressing constructs and then incubated at 37ºC for 24 h. The culture media were collected and centrifuged at 400 x g for 5 min to remove cell debris. LDH release in the media was measured at OD 490. The relative LDH release was expressed as the percentage LDH activity in supernatants of cultured cells (medium) compared with total LDH (from media and the cells) and used as an index of cytotoxicity.
Lysosomal Membrane Permeabilization (LMP) assay
Human neutrophils were isolated as described above and cultured for indicated times. Lysosomal membrane permeability was then assayed as previously described (Loison et al., 2014) . Briefly, cells were stained with Acridine Orange (2 ug/ml) in RPMI plus 10 % FCS for 15 min at 37 
Preparation of neutrophil cytosolic fraction
Purified neutrophils were washed once with ice cold PBS then incubated for 30 min on ice in hypotonic buffer (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1 mM DTT) supplemented with protease inhibitor cocktail (Roche, Basel, Switzerland). Cells were then lysed by 20-30 strokes of a Dounce homogenizer with pestle B. Extracts were then centrifuged at 16,000 x g at 4°C for 30 min. Supernatants were collected as cytosolic fractions.
Immunofluorescent staining
For immunostaining of GSDMD, HEK293T cells were plated onto 18 mm diameter, #1.5 thickness glass coverslips (NeuVitro Corp., El Monte, CA) in 6-well plates overnight. Cells were transfected with 1ug of indicated 3xFLAG-tagged GSDMDs and incubated for 24 h. Cells were fixed for 30 min in 3% paraformaldehyde (PFA) before being washed three times with PBS and permeabilized for 15 min with 0.25% saponin in PBS. Blocking was performed with 2% BSA in PBS for 30 min at RT. The diluted primary anti-FLAG antibodies (1:2000) were added and incubated overnight at 4°C. After three washes with PBS, the Alexa fluor 594 dye-conjugated secondary antibody (1:1000) was added and incubated for 1 h at room temperature. Staining was visualized using the Olympus Fluoview FV1000 confocal system and images were taken using a 60x objective lens. Complete depletion of Gsdmd mRNA in the KO mice was confirmed by qPCR. (F) Total white blood cell count (WBC) in wild-type (WT) and Gsdmd-deficient (KO) mice (n >15 mice per genotype). No significant difference (P < 0.05) was found between groups. (G) Differential white blood cell counts, red blood cell (RBC) counts, platelets (PLT) counts, and hemoglobin (HGB) levels in WT and KO mice (n >15 mice per genotype). No significant difference (P < 0.05) was found between groups. (H) Peripheral blood smears from WT and KO mice. Shown are representative images. (I) Survival rates of mice challenged with lethal sepsis. Age and sex matched (9-week old, n=6) mice were challenged with 30 mg/kg LPS (E.coli 0111:B4). Survival rates were analyzed using the Kaplan-Meier survival curves and log-rank test. * P < 0.05 vs WT. (J) Relative ratio of spleen weight vs. body weight following E. coli challenge. The overall weight of each mouse was similar, so correction of spleen weight by body weight did not affect the conclusions. Values are mean ± SD. *P < 0.01 (Student's t-test). (K) Picture of spleens from unchallenged and E. coli challenged WT and KO mice. Experiments were conducted as described in Fig 1A. Figure S2. Related to Figure 3 . The elevated neutrophil accumulation in GSDMD-deficient mice was due to delayed neutrophil death. (A) Total white blood cell count (WBC), differential white blood cell counts, red blood cell (RBC) counts, platelets (PLT) counts, and hemoglobin (HGB) levels in wild-type (WT) and Gsdmd-deficient (KO) mice (male, 8-12 week old) after E.coli challenge. The experiments were conducted as described in Fig. 2E . No significant difference (P < 0.05) was found between groups. (B) The numbers of resident and inflammatory macrophages in the peritoneal cavity in WT and Gsdmd-deficient (KO) mice. The macrophages were identified by morphology examination of Wright-Giemsa stained peritoneal cells (large size, large cytoplasmic region, and single, round nucleus). All values represent mean ± SD of three independent experiments. (C) Clearance of dead neutrophils by macrophages (efferocytosis). The assay was conducted as previously described (Mondal et al., 2011) . Briefly, wild-type or Gsdmd-deficient (KO) peritoneal macrophages were incubated with one-day cultured bone marrow neutrophils at a density of (1:10) for 90 minutes at 37°C. Cells were washed and efferocytosis was analyzed by HEMA3 staining. Number of macrophages containing one or more apoptotic cell was scored as % efferocytosis. Arrowheads indicate macrophage containing engulfed apoptotic cells. All values represent mean ± SD of three independent experiments. (D) Representative flow cytometry plots for peritoneal neutrophils in unchallenged WT and Gsdmd-deficient (KO) mice. Numbers denote the frequency of each population among live singlets. Very few neutrophils were detected in the peritoneal cavity of WT or KO mice. (E) Gating strategy to analyze neutrophil death in inflamed peritoneal cavities in WT and KO mice. The experiments were conducted as described in Fig. 3C . Gating strategy to analyze the death of in vitro cultured WT and Gsdmd-deficient (KO) neutrophils. In this FACS-based analysis, the characteristic phosphatidylserine exteriorization was detected by annexin V, an anticoagulant protein that has high affinity and selectivity for phosphatidylserine. The membrane integrity of the dying neutrophils was monitored using propidium iodide (PI), a membrane impermeable dye. Experiments were conducted as described in Fig 3E. (B In vitro phagocytosis assay. Human neutrophils were cultured in the presence or absence of Sivelestat (1μg/ml) for 24 hr. Fluorescein-conjugated E. coli bioparticles (10 µg/ml) were opsonized with 20% human serum and incubated with survived neutrophils at 37°C for 90 min. Cells were fixed with 4% PFA and phagocytosed bioparticles were manually counted to determine phagocytosis efficiency and index. (B) Neutrophil chemotaxis assay. Neutrophil chemotaxis was assessed using EZ-Taxiscan chemotaxis device (Effector Cell Institute, Tokyo, Japan) as previously described (Hattori et al., 2010; Sakai et al., 2012) . Chemotaxis was triggered by fMLP (1 µl of 0.1 µM human fMLP, Sigma: F3506). Chemotaxis speed, directionality and upward directionality were calculated using Gradientech Tracking Tool™ PRO v2.1. All values represent mean ± SD (n=20 cells). 
